These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 9229948)

  • 1. [Fleroxacin--a new quinolone antibiotic].
    Kostić D
    Vojnosanit Pregl; 1996; 53(4):311-24. PubMed ID: 9229948
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro activities of newly developed quinolones, fleroxacin, lomefloxacin and sparfloxacin against Mycobacterium tuberculosis].
    Kawahara S; Kamisaka K; Tada A; Nakada H; Mishima Y; Yoshimoto S; Matsuyama T; Kibata M; Nagare J
    Kekkaku; 1991 Jun; 66(6):429-31. PubMed ID: 1942726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The serum bactericidal activity of domestic fleroxacin and lomefloxacin].
    Zhao M; Jiang S; Wang R
    Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):98-100. PubMed ID: 11798634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.
    Pattyn SR
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):613-7. PubMed ID: 1666402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activity of antifungal agents in combination with fleroxacin, a new quinolone.
    Polak A
    Mycoses; 1990 Apr; 33(4):173-8. PubMed ID: 2122247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical study in the treatment of acute bacterial infections with fleroxacin].
    Hou J; Li J; Cui H
    Zhonghua Nei Ke Za Zhi; 1996 Oct; 35(10):663-7. PubMed ID: 9592325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute, uncomplicated, lower urinary tract infections: the role of single-dose fleroxacin.
    Kosmidis J; Gargalianos P; Lelekis M; Adamis G; Petropoulou D; Makris D
    J Chemother; 1989 Jul; 1(4 Suppl):864-5. PubMed ID: 16312675
    [No Abstract]   [Full Text] [Related]  

  • 8. 1H and 19F NMR relaxation studies of fleroxacin with Micrococcus luteus.
    Waibel B; Holzgrabe U
    J Pharm Biomed Anal; 2007 Apr; 43(5):1595-601. PubMed ID: 17254731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of acid-base equilibria of fleroxacin.
    Popović G; Milovanović L; Kapetanović V
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):859-63. PubMed ID: 9919988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro susceptibility of Campylobacter jejuni and Campylobacter coli to quinolone antibiotics].
    Gür D; Hasçelik G; Akyön Y; Akalin HE; Diker S
    Mikrobiyol Bul; 1989 Jul; 23(3):185-9. PubMed ID: 2518646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro.
    Ebisuno S; Inagaki T; Kohjimoto Y; Ohkawa T
    Cancer; 1997 Dec; 80(12):2263-7. PubMed ID: 9404703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial activity of 1-(2-fluorovinyl)-7-substituted-4-quinolone-3-carboxylic acid derivatives, conformationally restricted analogues of fleroxacin.
    Asahina Y; Iwase K; Iinuma F; Hosaka M; Ishizaki T
    J Med Chem; 2005 May; 48(9):3194-202. PubMed ID: 15857125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
    Beskid G; Prosser BL
    Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fleroxacin: a new once-a-day quinolone. Symposium proceedings. Turnberry Isle, Florida, April 21-24, 1992.
    Am J Med; 1993 Mar; 94(3A):1S-204S. PubMed ID: 8095772
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
    Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fleroxacin treatment for acute uncomplicated cystitis in women: comparison of 3-day and 7-day therapy].
    Ishihara S; Ban Y; Kawada Y; Ito S; Ito Y; Doi T; Nezasa S; Fujihiro S; Yamaha M; Ito F; Iwata H; Hasegawa Y; Ueno K; Shinoda I; Taniguchi M; Minoshima K; Takeuchi T; Sakai S; Uno H; Koide T
    Hinyokika Kiyo; 1998 Jun; 44(6):431-6. PubMed ID: 9719946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Encephalopathy induced by fleroxacin in a patient with Machado-Joseph disease].
    Kimura M; Fujiyama J; Nagai A; Hirayama M; Kuriyama M
    Rinsho Shinkeigaku; 1998 Sep; 38(9):846-8. PubMed ID: 10078039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of roxithromycin combined with fleroxacin on bacterial biofilm induced by Pseudomonas aeruginosa].
    Chen Q; Wang R; Fang X
    Zhonghua Yi Xue Za Zhi; 1999 Oct; 79(10):757-60. PubMed ID: 11715522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and antibacterial activity of 7-substituted-1-ethyl(2-fluoro-ethyl)-6,8-difluoro-1,4-dihydro-4- oxoquinoline-3-carboxylic acid].
    Yan L; Xu B; Ma Z; Zhu Y; Yang Q
    Yao Xue Xue Bao; 1998 May; 33(5):392-5. PubMed ID: 12017009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell compatibility of fluoroquinolone solutions for intravenous use.
    Vorbach H; Weigel G; Robibaro B; Schaumann R; Hlousek M; Beil WJ; Griesmacher A; Georgopoulos A; Graninger W
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):235-8. PubMed ID: 9208338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.